Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy

OBJECTIVE: Use of tumour necrosis factor inhibitors (TNFi) has proved to be an important step forward in the treatment of axial spondyloarthritis (axSpA), but the duration of the therapy as well as the management in case of low disease activity (LDA) or remission are not clearly established. Current...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Reumatologia
Hlavní autoři: Sebastian, Agata, Wojtala, Patryk, Lubiński, Łukasz, Mimier, Małgorzata, Chlebicki, Arkadiusz, Wiland, Piotr
Médium: Artigo
Jazyk:Inglês
Vydáno: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2017
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5647530/
https://ncbi.nlm.nih.gov/pubmed/29056769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2017.69775
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky